Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.
Patriarca F, Medeot M, Isola M, Battista ML, Sperotto A, Pipan C, Toffoletti E, Dozzo M, Michelutti A, Gregoraci G, Geromin A, Cerno M, Savignano C, Rinaldi C, Barbone F, Fanin R.
Patriarca F, et al. Among authors: dozzo m.
Transpl Infect Dis. 2013 Jun;15(3):259-67. doi: 10.1111/tid.12061. Epub 2013 Feb 13.
Transpl Infect Dis. 2013.
PMID: 23405972